Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure from was processed by Pulse News Wire on January 15, 2026. It represents a primary source document for Japanese Corporate sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
Source disclosure: January 15, 2026 CellSeed Inc. [7776.T] TOKYO, Jan 15 (Pulse News Wire) – CellSeed Inc. (7776.T) reported significant exercise of its 25th series warrants during the period from January 5 to January 15, 2026. A total of 12,615 warrants were exercised, representing a ratio of 14.66% of the outstanding warrant issuance of 86,000 units. As of the end of December 2025, there were 77,087 unexercised warrants. By January 15, 2026, this number had decreased to 64,472 une